Michelle Se Won Min

Picture of Michelle Se Won Min
Assistant Clinical Professor, Dermatology
School of Medicine
Director of Rheumatologic-Dermatology, Dermatology
School of Medicine
M.D., Boston University School of Medicine
Phone: (949)824-5515
Email: minms@uci.edu
University of California, Irvine
118 Medical Surge 1
Irvine, CA 92697
Research Interests
Academic Distinctions
* Dermatology Residency, Chief Resident (New York, NY) 2019 – 2020
* Program Evaluation Committee, Class Representative (New York, NY) 2017 – 2020
* Wellness/Mentorship, Resident Organizer (New York, NY) 2018 – 2019
* Atlantic Derm Conference, Planning Committee Member (New York, NY) 2018 – 2019
* Student Committee on Medical Student Affairs, Chair (Boston, MA) 2011 – 2016
* Brigham and Women’s Hospital, Harvard Medical School (Boston, MA) July 2020 – Present
Dermatology-Rheumatology Fellowship
* Icahn School of Medicine, Mount Sinai (New York, NY) July 2017 – June 2020
Dermatology Residency, Advanced - Chief Resident
* St Elizabeth’s Medical Center, Tufts University (Boston, MA) June 2016 – June 2017
Internal Medicine Residency, Preliminary
* Boston University School of Medicine (Boston, MA) May 2016
Doctor of Medicine
* Icahn School of Medicine, Mount Sinai (New York, NY) July 2014 – June 2015
Biologics/Infusion Dermatology Fellowship
* University of Pennsylvania (Philadelphia, PA)
Master of Science, Submatriculation program October 2010
> Master of Chemistry
> Bachelor of Arts May 2010
1. Elsanadi R, Yale K, Rojek N, Zhao D, Lee B, Min MS. A case of interstitial granulomatous dermatitis presenting in a patient with necrotizing sarcoid granulomatosis. JAAS Case Rep. Accepted June 2023.
2. Min MS, Goldman N, Mazori DR, Guo LN, Vleugels RA, LaChance AH*. Hyaluronidase injections for oral microstomia: a study in systemic sclerosis and mixed connective tissue disease. JAMA Dermatol. Submitted May 2023. *co-corresponding authors
3. O’Connell KA, Schaefer M, Atzmony L, Vleugels RA, Choate K, LaChance AH, Ming MS. Clinical features in adults with acquired cutis laxa: a retrospective review. Br J Dermatol. 2023 May 24;188(6):800-816.
4. Ganske IM, Cappitelli AT, Langa OC, Min M, Torok KS, Dedeoglu F, Vleugels R. Pilot use of 3-dimensional photography to aid clinical decision-making in craniofacial morphea. JAAD Case Rep. 2022 June 7;25:100-103.
5. Min MS, Mazori DR, Kassamali B, Cobos G, Ho A, LaChance AH, Vleugels RA*. Treatment with mycophenolate mofetil for salt-and-pepper dyspigmentation caused by autoimmune sclerosing disease. JAMA Dermatol. 2022;158(3):327-329. *Co-corresponding authors
6. Min MS, Kassamali B, Mazori DR, Gizelis O, Schaefer M, Ho A, Merola JF, Cobos G, LaChance AH, Vleugels RA. Lack of association between tumor necrosis factor-a inhibitor use and exacerbation of lupus erythematosus: a retrospective cohort study. J Am Acad Dermatol. 2022;86(5):1180-1182.
7. Min MS*, Kus K, Wei N, Kassamali B, Faletsky A, Mostaghimi A, Lebwohl MG. Evaluating the role of histopathology in diagnosis pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicentre, retrospective cohort study. Br J Dermatol. 2022;186(6):1035-1037. *Corresponding author
8. Min MD, Kassamali B, Mazori DR, Vleugels RA, Merola JF, Cobos G, LaChance AH. The catch-22 of limited Food and Drug Administration approval for connective tissue disease therapies. J Am Acad Dermatol.2021;85(2):517-519.
9. Ghatnekar S, Shah N, Min MS, Mazori DR, LaChance AH, Vleugels RA, Nambudiri VE. Clinical features and eosinophilia in pityriasis rubra pilaris: a multicenter cohort. J Am Acad Dermatol. 2022;86(4):907-909.
10. Kassamali B, Villa-Ruiz C, Mazori DR, Min M, Cobos GA, LaChance AH. Characterizing top educational TikTok videos by dermatologists in response to “TikTok and dermatology: An opportunity for public health engagement”. J Am Acad Dermatol. 2021;85(1):e27-e28.
11. Kassamali B, Kus KJB, Min MS, Cobos GA, LaChance AH, Mazori DR. Importance of nose wires in fabric face masks in reply to: “Diagnostic and management considerations for “maskne” in the era of COVID-19”. J Am Acad Dermatol. 2021;157(7):880-882.
12. Mazori DR, Min MS, Kassamali B, Brichta L, Cobos GA, Merola JF, Vleugels RA, LaChance AH. Novel use of tofacitinib 2% ointment for periorbital discoid lupus erythematosus. JAMA Dermatol. 2021 Jul 1;157(7):880-882.
13. Min MS*, Alsarheed A, Kassamali B, Mazori DR, Schaefer M, Merola JF, Cobos G, LaChance AH, Vleugels RA*. Tofacitinib as treatment for refractory dermatomyositis: A retrospective study from two academic medical centers. J Am Acad Dermatol. 2022;86(2):423-425. *Co-corresponding authors
14. Kassamali B, Desai S, Min MS, Mazori DR, Cobos GA, LaChance A, Vleugels RA. A multi-institutional study examining the efficacy of and challenges in attaining insurance approval for botulinum toxin injections for systemic sclerosis-associated Raynaud’s phenomenon. J Drugs Dermatol. Accepted 2021.
15. Kassamali B, Kus KJB, Min MS, Villa-Ruiz C, Cobos GA, Merola JF, Vleugels RA, Mazori DR, LaChance AH. Characteristics and treatment of silicone granulomas: A retrospective multicenter cohort of 21 patients. JAAD Intl. 2021;3:111-114.
16. O’Connell KA, Min MS*, LaChance AH*. Bright red macules of the lower legs. JAMA Dermatol. 2021;157(9):1118-1119. *Co-senior and co-corresponding authors
17. Min MS*, Mazori Dr, Lee MS, Merola JF, Vleugels RA, Cobos G, LaChance AH*. Successful treatment of multiple keloids and hypertrophic scars with systemic and intralesional dupilumab. J Drugs Dermatol. Submitted 2021. *Co-corresponding authors
18. Kassamali B, Desai S, Min M, Mazori D, Villa-Ruiz C, Kus K, Cobos G, Merola J, LaChance A, Vleugels R. Onabotulinumtoxin A for systemic sclerosis-associated Raynaud’s phenomenon: A multi-institutional study on accessibility and effectiveness. J Drugs Dermatol. 2021;20(11):1257-1259.
19. Mazori DR, Kassamali B, Min MS, Schaefer M, LaChance AH, Sperling AS, Vleugels RA. Characteristics and outcomes of eosinophilic fasciitis-associated monoclonal gammopathy. JAMA Dermatol. 2021;157(12):1508-1509.
20. Kassamali B, Min MS*, LaChance AH*. A benign-appearing subcutaneous cyst in an immunocompromised patient: challenge. Am J Dermatopath. Submitter 2021. *Co-senior and co-corresponding authors
21. Mazori DR, Min MS, Schaefer M, Imadojemu SE, Ho AW, Cobos GA, Vleugels RA. Treatment of the lupus pernio variant of sarcoidosis with oral tofacitinib. JAMA Dermatol. Submitted 2021.
22. Mazori DR, Alsarheed A, Min MS, Schaefer M, Ho AW, Cobos GA, Vleugels RA. Anti-MDA5 dermatomyositis following hand-foot-and-mouth disease: Insights into potential disease pathogenesis. JAMA Dermatol. Submitted 2021.
23. Min MS, Kurtzman DJB, Vleugels RA, Callen JP. Clinical Features: Cancer-Associated Myositis (CAM). Book Chapter. Submitted 2021.
24. Lee MS, Klebanov N, Quattrochi B, Murphy G, Min MS*, LaChance A*. A 44-year-old woman with violaceous, ulcerated plaques in a dermatomal distribution. New England Dermatological Society. 2021: Case XIII. *Co-senior authors
25. Min MS, Wu J, He H, Sanz-Cabanillas JL, Del Duca E, Zhang N, Renert-Yuval Y, Pavel AB< Lebwohl M, Guttman-Yassky E. Granuloma annulare skin profile shows activation of Th1, Th2, and JAK pathways. J Am Acad Dermatol. 2020;83(1):63-70.
26. Villa-Ruiz C, Kassamali B, Mazori DR, Min M, Cobos G, LaChance A. Overview of TikTok’s most viewed dermatologic content and assessment of its reliability. J Am Acad Dermatol. 2021;85(1):273-274.
27. Fenner J, Min MS, Liu S, Silverberg N. A case of neonatal pemphigus vulgaris with co-existing BP180 autoantibodies. Pediatr Derm. 2020;37(1):241-243.
28. Min M, Anvekar R, Wu J, Liu S, Phelps R. Lupus profundus recalcitrant to systemic therapy. ADC 2019 Patient Viewing Casebook. 2019:12-13.
29. Min M, Ryu B, Alani R. Cell cycle activators and tumor suppressors that correlate with melanoma progression. SKIN The Journal of Cutaneous Medicine. 2019;3(2):144.
30. Min MS, Damstetter E, Chen AYY. Autoimmune blistering disorders in the setting of human immunodeficiency virus infection. Int J Womens Dermatol. 2018;4(3):159-165.
31. Khattri S, Goldblum O, Solotkin K, Amir Y, Min MS, Ridenour T, Yang FE, Lebwohl M. Early onset of clinical improvement with izekizumab in a randomized, open-label study of patients with moderate-to-sever plaque psoriasis. J Clin Aesthet Dermatol. 2018;11(5):33-37.
32. Min MS*, Phelps R, Levitt J. Recurrent lupus profundus-like panniculitis associated with streptococcal throat infections in an immunocompetent child. JAAD Case Rep. 2018;4(4):359-361.
33. Min MS, Al-Haseni, Succaria F, Goldberg L, Lerne A, Sahni D. Anaplastic large cell lymphoma localized to the left breast years after radiotherapy for breast cancer. Dermatol Online J. 2018;24(1):pii:13030/qt7940069z.
34. Min MS*, Yao J, Chee N, Sapadin AN, Shim-Chang H. Xanthogranulomuatous reaction to trametinib for metastatic malignant melanoma. Cutis. 2018;102(4):283-286. *Corresponding author
35. Mansouri Y, Amir Y, Min M, Khanna R, Huang R, Suarez-Farinas M, Lebwohl M. Impact of temperature on injection-related pain caused by subcutaneous administration of ustekinumab: a three-arm crossover open-label randomized controlled trial. SKIN The Journal of Cutaneous Medicine. 2017;1(3):117-127.
36. Min MS, Lebwohl M. Treatment of recalcitrant granuloma annulare with adalimumab: A single-center, observational study. J Am Acad Dermatol. 2016;74(1):127-33.
37. Guttman-Yassky E, Ungar B, Noda S, Suprun M, Shroff A, Dutt R, Khattri S, Min M, Mansouri Y, Zheng X, Estrada YD, Singer GK, Saurez-Farinas M, Krueger JG, Lebwohl MG. Extensive alopecia areata is reversed by IL-12/IL-23 p 40 cytokine antagonism. J Allergy Clin Immunol. 2016;137(1):301-304.
38. Min MS, Shroff A, Rose S, Lebwohl M, Guttman-Yassky E. Usetkinumab as therapy for psoriasis in a 2-year-old girl. J Eur Acad Dermatol Venereol. 2016;30(11):e109-e110.
39. Min MS*, Fischer R, Fournier J. Unilateral erythema nodosum following norethindrone acetate, ethinyl estradiol, ferrous fumarate combination therapy. Case Rep Obstet Gynecol. 2016;2016:5726416. *Corresponding author
40. Hwang S, Kim HE, Min M, Raghunathan R, Panova I, Munshi R, Ryu B. Epigenetic silencing of SPINT2 promotes cancer cell motility via HGF-MET pathway activation in melanoma. J Invest Dermatol. 2015;135(9):2283-91.
41. Min MS, Yao J, Kim SJ. Development of a reticular rash in a febrile woman: An unusual cutaneous presentation of angioimmunoblastic T-cell lymphoma. J Am Acad Dermatol Case Reports. 2015;1(3):160-2.
42. Yu Z, Goodman LD, Shieh SY, Min M, Teng X, Zhu Y, Bonin NM. A fly model for the CCUG-repeat expansion of myotonic dystrophy type 2 reveals a novel interaction with MBNL 1. Hum Mol Genet. 2015;24(4):954-62.
43. Xue K*, Min M*, Gelfand M, Ortega R. Anesthesiology through the lens of a traditional Chinese medicine. Bull Anesth Hist. 2014;32(1):16-20. *Co-first authors.
Professional Societies
American Academy Dermatology, Member 2017 – Present
Women’s Dermatologic Society, Member 2017 – 2021
American Society for Dermatologic Surgery, Member 2017– 2021
American Society for Laser Medicine and Surgery, 2017-2021
Rheumatologic Dermatology Society, Member 2020 – Present
Gold Humanism Honor Society, Member 2015 – Present
American Medical Association, Member 2011 – Present
Dermatologic Society of Greater New York, Member 2017 – 2020
Massachusetts Medical Society, Member 2011 – 2021
Orange County Dermatologic Society, 2022-Present
Other Experience
Co-Investigator/Dermatology-Rheumatology Fellow (Boston, MA)
Brigham and Women’s Hospital at Harvard Medical School, Department of Dermatology 2020—2021
Resident Researcher (New York, NY)
Icahn School of Medicine at Mount Sinai, Department of Dermatology 2017—2020
Biologics and Clinical Research Fellow (New York, NY)
Icahn School of Medicine at Mount Sinai, Department of Dermatology 2014—2015
Medical Student Research Assistant (Boston, MA)
Boston University School of Medicine, Department of Dermatology 2012—2013
HHMI Student Research Assistant (Philadelphia, PA)
University of Pennsylvania, Howard Hughes Medical Institute, Department of Neuroscience 2007—2011
Last updated